Back to search
FDAFDA · Food and drugs·Recall number D-1609-2014

Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03

Published October 1, 2014 · Recall initiated: April 18, 2014

Summary

FDA records drug Class III recall D-1609-2014, published October 1, 2014 and initiated April 18, 2014. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 5,397 bottles; Lot: Lot # KM4951; Exp. 04/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Corp.
Distributor
Nationwide.
Lot
Lot # KM4951; Exp. 04/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03 recalled?

Yes. FDA published recall D-1609-2014 on October 1, 2014. Reported hazard: Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter